Genital Herpes Simplex – A Complete Patient‑Friendly Guide
Overview
Genital herpes is a common sexually transmitted infection (STI) caused by the herpes simplex virus (HSV). Two types exist:
- HSV‑1 – traditionally associated with oral cold sores, but now a leading cause of genital infections in many countries.
- HSV‑2 – historically the primary cause of genital herpes.
Both viruses produce the same clinical picture when they infect the genital area. The infection is lifelong; after the initial outbreak the virus retreats to nerve cells and can reactivate periodically.
Who it affects
- Both men and women are susceptible.
- Most new infections occur in people aged 15–35 years, the age range of highest sexual activity.
- People with weakened immune systems (e.g., HIV, organ‑transplant recipients) are at higher risk for severe disease.
Prevalence
- According to the CDC, an estimated 12 % of U.S. adults (≈ 48 million people) are infected with HSV‑2.
- Globally, the World Health Organization estimates that **≈ 500 million people** live with HSV‑2, making it the most common cause of genital ulcer disease worldwide.
- HSV‑1 genital infections have risen dramatically, especially in young adults; in some European studies, > 30 % of first‑time genital herpes cases are caused by HSV‑1.
Symptoms
Many people with genital herpes have mild or no symptoms, especially during their first infection. When symptoms do appear, they typically develop within 2–12 days after exposure.
Primary (first) outbreak
- Painful blisters or vesicles on the external genitalia, perianal area, inner thighs, or buttocks.
- Ulcers that break open, crust over, and heal in 2–3 weeks.
- Systemic signs: fever, headache, muscle aches, swollen lymph nodes in the groin, and malaise.
- Urinary discomfort: burning during urination if lesions involve the urethra.
Recurrent (subsequent) outbreaks
- Often milder and shorter lasting (3–7 days).
- May be preceded by a prodrome—tingling, itching, or burning sensation in the area where lesions will appear.
- Typical locations: labia, penis shaft, perianal skin, or vaginal opening.
- Some individuals experience only *asymptomatic shedding*—viral particles released without visible lesions, which still can transmit infection.
Other possible manifestations
- Herpetic meningitis (rare) – headache, stiff neck, fever after a genital outbreak.
- Neonatal herpes – if a pregnant woman acquires HSV near delivery, the newborn can develop severe disease.
- Herpes‑associated erythema multiforme – target‑shaped skin lesions, usually on the hands or feet.
Causes and Risk Factors
How the virus spreads
- Sexual contact: vaginal, anal, or oral sex with an infected partner.
- Skin‑to‑skin contact with an active lesion or with asymptomatic shedding skin.
- Vertical transmission: from mother to baby during childbirth (especially with a primary HSV‑2 infection in late pregnancy).
Key risk factors
- Having multiple sexual partners or a new partner.
- Inconsistent or no condom use.
- History of other STIs (e.g., chlamydia, gonorrhea) which can disrupt mucosal barriers.
- Immunosuppression (HIV infection, chemotherapy, corticosteroid therapy).
- Poor genital hygiene that creates micro‑abrasions.
- Women: hormonal changes during pregnancy or menstrual cycle may increase reactivation frequency.
Diagnosis
Because many infections are asymptomatic, testing is often performed in the context of routine STI screening, partner notification, or when symptoms appear.
Clinical examination
- Visual inspection of lesions by a clinician. Classic “grouped vesicles on an erythematous base” is suggestive.
- Note: A visual diagnosis alone cannot differentiate HSV‑1 from HSV‑2.
Laboratory tests
- Polymerase chain reaction (PCR) assay – the gold standard; detects viral DNA from lesion swabs, urine, or blood. Sensitivity > 95 %.
- Viral culture – less commonly used now, requires a fresh lesion sample; sensitivity declines after 48 h.
- Type‑specific serology (blood test for HSV‑1 & HSV‑2 IgG antibodies). Helpful for patients with atypical symptoms or for counseling about future risk.
- Direct fluorescent antibody (DFA) testing – rapid but less sensitive than PCR.
When testing is recommended
- First genital ulcer or unexplained rash.
- Pregnant women with a history of genital lesions.
- Individuals with frequent recurrences or atypical presentations.
- Partner of a known HSV‑positive person who wants confirmation of status.
Treatment Options
There is no cure; therapy aims to shorten outbreaks, relieve symptoms, and reduce transmission risk**.
Antiviral medications
| Drug | Typical dose (adult) | Use |
|---|---|---|
| Acyclovir | 400 mg oral 5×/day for 7–10 days (primary) or 400 mg BID for suppressive therapy | First‑line; inexpensive |
| Valacyclovir | 1 g oral BID for 7–10 days (primary) or 500 mg daily suppressive | Better bioavailability, fewer pills |
| Famciclovir | 250 mg oral TID for 7–10 days (primary) or 250 mg BID suppressive | Alternative for those intolerant to acyclovir |
**Suppressive therapy** (daily antiviral) reduces recurrence frequency by 70‑80 % and lowers transmission to partners by ~50 % (CDC, 2020).
Procedural options (rare)
- Topical anesthetics (e.g., lidocaine gel) for pain relief during outbreaks.
- Cryotherapy or laser ablation – occasionally used for persistent non‑healing lesions, but not standard care.
Lifestyle & supportive care
- Cool compresses to reduce pain and swelling.
- Keep the affected area clean and dry; gentle soap and water.
- Over‑the‑counter pain relievers (acetaminophen or ibuprofen) for discomfort.
- Avoid sexual activity while lesions are present to prevent spread.
Living with Genital Herpes
Most people lead normal, healthy lives with proper management.
Daily management tips
- Know your triggers: stress, illness, menstrual cycle, and excessive sunlight can reactivate HSV. Keep a symptom diary.
- Maintain genital hygiene: gentle washing, change out of wet clothing promptly.
- Use condoms consistently: they reduce but do not eliminate transmission because HSV can affect skin not covered by a condom.
- Communicate with partners: disclose status, discuss suppressive therapy, and consider testing.
- Take antivirals as prescribed: even if you feel well, daily suppressive therapy can keep viral shedding low.
- Vaccination status: there is currently no approved HSV vaccine, but staying up‑to‑date on HPV and hepatitis B vaccines helps overall sexual health.
Psychosocial support
- Join support groups (online or local) – many find relief sharing experiences.
- Consider counseling if anxiety or depression related to the diagnosis arises.
- Reliable information (e.g., from CDC, Mayo Clinic) combats stigma.
Prevention
- Consistent barrier protection: Use latex or polyurethane condoms for every sexual act.
- Dental dams for oral‑genital contact.
- Limit number of sexual partners and discuss STI testing openly.
- Avoid sexual activity during an outbreak or when prodromal symptoms appear.
- Consider daily suppressive antiviral therapy if you have frequent recurrences or a partner who is HSV‑negative.
- For pregnant women with HSV, a **cesarean delivery** is recommended if active lesions are present at labor onset to protect the newborn.
Complications
While most cases are benign, complications can arise, especially without treatment.
- Neonatal herpes: mortality up to 50 % without prompt therapy; can cause severe brain damage.
- Genital scarring or adhesions from recurrent ulcerations (rare).
- Psychological impact: anxiety, depression, and relationship strain.
- Increased HIV acquisition risk: genital ulcers provide an entry portal; HSV infection doubles the risk of HIV transmission (WHO, 2021).
- Herpes keratitis (if HSV‑1 spreads to the eye) – not directly genital but possible after autoinoculation.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Severe, unrelenting pain that does not improve with over‑the‑counter medication.
- Fever > 101 °F (38.3 °C) accompanied by a headache, neck stiffness, or confusion – possible meningitis.
- Rapidly spreading lesions, especially if they become necrotic or develop a foul odor.
- Difficulty urinating or a sudden loss of bladder control.
- Newborn with blisters, seizures, or lethargy – could be neonatal herpes.
- Signs of an allergic reaction to medication (hives, swelling of the face or throat, difficulty breathing).
References
- Centers for Disease Control and Prevention (CDC). Genital Herpes – CDC Fact Sheet, 2023. https://www.cdc.gov/std/herpes/default.htm
- World Health Organization (WHO). Herpes simplex virus epidemiology, 2021.
- Mayo Clinic. Genital herpes: Symptoms and causes, 2022.
- National Institutes of Health (NIH) – National Library of Medicine. Herpes Simplex Virus Infections, UpToDate, 2024.
- Cleveland Clinic. Herpes Management: Antiviral Therapy, 2023.
- American Academy of Dermatology. Guidelines for Diagnosis and Management of Genital Herpes, 2022.